US Patent Issued to BOLT BIOTHERAPEUTICS on July 14 for "Anti-HER2 immunoconjugates, and uses thereof" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,513, issued on July 14, was assigned to BOLT BIOTHERAPEUTICS INC. (Redwood City, Calif.).

"Anti-HER2 immunoconjugates, and uses thereof" was invented by Shelley Erin Ackerman (Redwood City, Calif.), Michael N. Alonso (Redwood City, Calif.), Romas Kudirka (Redwood City, Calif.), Arthur Lee (Redwood City, Calif.), Brian Safina (Redwood City, Calif.) and Matthew Zhou (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides immunoconjugates of Formula I comprising an anti-HER2 antibody linked by conjugation to one or more 8-Het-2-aminobenzazepine derivatives. The invention also provides 8-Het-2-aminobenzazepine derivat...